Cargando…

Oral Cladribine Impairs Intermediate, but Not Conventional, Monocyte Transmigration in Multiple Sclerosis Patients across a Model Blood-Brain Barrier

Multiple sclerosis (MS) is a disease in which the immune system damages components of the central nervous system (CNS), leading to the destruction of myelin and the formation of demyelinating plaques. This often occurs in episodic “attacks” precipitated by the transmigration of leukocytes across the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Linda Y., Juillard, Pierre, Hawke, Simon, Marsh-Wakefield, Felix, Grau, Georges E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094666/ https://www.ncbi.nlm.nih.gov/pubmed/37047460 http://dx.doi.org/10.3390/ijms24076487

Ejemplares similares

Cladribine Reduces Trans-Endothelial Migration of Memory T Cells across an In Vitro Blood–Brain Barrier
por: Ford, Rachel K., et al.
Publicado: (2022)

Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis
por: Aglas-Leitner, F. T., et al.
Publicado: (2022)

Trans-Endothelial Migration of Memory T Cells Is Impaired in Alemtuzumab-Treated Multiple Sclerosis Patients
por: Nguyen, Kristy, et al.
Publicado: (2022)

Circulating CCR6 (+) ILC proportions are lower in multiple sclerosis patients
por: Aglas‐Leitner, Florentina, et al.
Publicado: (2022)

Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis
por: Sorosina, Melissa, et al.
Publicado: (2022)

Peripheral B‐cell dysregulation is associated with relapse after long‐term quiescence in patients with multiple sclerosis
por: Marsh‐Wakefield, Felix, et al.
Publicado: (2022)

HIV Tat-Mediated Induction of Monocyte Transmigration Across the Blood–Brain Barrier: Role of Chemokine Receptor CXCR3
por: Niu, Fang, et al.
Publicado: (2021)

IgG(3) (+) B cells are associated with the development of multiple sclerosis
por: Marsh‐Wakefield, Felix, et al.
Publicado: (2020)

Transmigration of Trypanosoma brucei across an in vitro blood-cerebrospinal fluid barrier
por: Speidel, Annika, et al.
Publicado: (2022)

Optimization of an in vitro human blood–brain barrier model: Application to blood monocyte transmigration assays
por: Paradis, Alexandre, et al.
Publicado: (2015)

Transmigration of Neural Stem Cells across the Blood Brain Barrier Induced by Glioma Cells
por: Díaz-Coránguez, Mónica, et al.
Publicado: (2013)

Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis
por: Sluiter, Thijs J., et al.
Publicado: (2021)

Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
por: Savic, Radojka M., et al.
Publicado: (2017)

Transmigration of polymorphnuclear neutrophils and monocytes through the human blood-cerebrospinal fluid barrier after bacterial infection in vitro
por: Steinmann, Ulrike, et al.
Publicado: (2013)

A Role for the αvβ3 Integrin in the Transmigration of Monocytes
por: Weerasinghe, Dheepika, et al.
Publicado: (1998)

The selective binding and transmigration of monocytes through the junctional complexes of human endothelium
Publicado: (1988)

Breakdown of the Endothelial Barrier Function in Tumor Cell Transmigration
por: Mierke, Claudia Tanja, et al.
Publicado: (2008)

COVID-19 in Cladribine-treated patient with multiple sclerosis
por: Haham, Nitsan, et al.
Publicado: (2021)

Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay
Publicado: (1992)

Resveratrol blunts tumor necrosis factor-α-induced monocyte adhesion and transmigration
por: Kim, Dong Shoo, et al.
Publicado: (2007)

Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
por: Schreiner, Teri L., et al.
Publicado: (2012)

The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
por: Hermann, Robert, et al.
Publicado: (2018)

Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment
por: Rolfes, Leoni, et al.
Publicado: (2021)

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
por: Allen-Philbey, Kimberley, et al.
Publicado: (2021)

COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
por: Buttari, Fabio, et al.
Publicado: (2021)

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

ADAM9 is present at endothelial cell - cell junctions and regulates monocyte – endothelial transmigration
por: English, William R., et al.
Publicado: (2017)

Cocaine-induced release of CXCL10 from pericytes regulates monocyte transmigration into the CNS
por: Niu, Fang, et al.
Publicado: (2019)

Zika virus enhances monocyte adhesion and transmigration favoring viral dissemination to neural cells
por: Ayala-Nunez, Nilda Vanesa, et al.
Publicado: (2019)

Monocyte-Derived miRNA-1914-5p Attenuates IL-1β–Induced Monocyte Adhesion and Transmigration
por: Toriuchi, Kohki, et al.
Publicado: (2023)

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
por: Gasperini, Claudio, et al.
Publicado: (2010)

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
por: Warnke, Clemens, et al.
Publicado: (2010)

No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
por: Pakpoor, Julia, et al.
Publicado: (2015)

Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
por: Ceronie, Bryan, et al.
Publicado: (2018)

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis
por: Afolabi, Dayo, et al.
Publicado: (2017)

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
por: Rammohan, Kottil, et al.
Publicado: (2020)

COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update
por: Jack, Dominic, et al.
Publicado: (2021)

Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment
por: Schönfelder, Kristina, et al.
Publicado: (2021)

Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
por: Giovannoni, Gavin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkudctn28e1d1rlk065n15q52v